DE69914911D1 - Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen - Google Patents

Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen

Info

Publication number
DE69914911D1
DE69914911D1 DE69914911T DE69914911T DE69914911D1 DE 69914911 D1 DE69914911 D1 DE 69914911D1 DE 69914911 T DE69914911 T DE 69914911T DE 69914911 T DE69914911 T DE 69914911T DE 69914911 D1 DE69914911 D1 DE 69914911D1
Authority
DE
Germany
Prior art keywords
prophylaxis
organisms
micro
controlling
pharmaceutical preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69914911T
Other languages
English (en)
Other versions
DE69914911T2 (de
Inventor
Jacob Swart
Elizabeth Kuipers
Klaas Meijer
Johan Hageman
Den Berg Johannes Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98203765A external-priority patent/EP0974360A3/de
Application filed by Nutricia NV filed Critical Nutricia NV
Publication of DE69914911D1 publication Critical patent/DE69914911D1/de
Application granted granted Critical
Publication of DE69914911T2 publication Critical patent/DE69914911T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69914911T 1998-06-26 1999-06-28 Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen Expired - Fee Related DE69914911T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
NL1009505 1998-06-26
NL1009505 1998-06-26
NL1010284 1998-10-09
NL1010284 1998-10-09
EP98203765A EP0974360A3 (de) 1998-06-26 1998-11-06 Pharmazeutische Präparate zur Bekämpfung oder Prophylaxe von Mikroorganismen infizierten Oberflächen
EP98203765 1998-11-06
PCT/EP1999/004067 WO2000000214A2 (en) 1998-06-26 1999-06-28 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms

Publications (2)

Publication Number Publication Date
DE69914911D1 true DE69914911D1 (de) 2004-03-25
DE69914911T2 DE69914911T2 (de) 2004-12-09

Family

ID=27239422

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69914911T Expired - Fee Related DE69914911T2 (de) 1998-06-26 1999-06-28 Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen

Country Status (8)

Country Link
EP (1) EP1089755B1 (de)
JP (1) JP2002519332A (de)
AT (1) ATE259654T1 (de)
AU (1) AU771077B2 (de)
CA (1) CA2332127A1 (de)
DE (1) DE69914911T2 (de)
NZ (1) NZ509101A (de)
WO (1) WO2000000214A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL363153A1 (en) * 2000-06-16 2004-11-15 Hercules Incorporated Chemically-modified antimicrobial peptides, compositions and methods of production and use
AU2001270098A1 (en) * 2000-06-22 2002-01-02 San Diego State University Foundation Recombination modulators and methods for their production and use
US7244438B2 (en) 2001-01-05 2007-07-17 Intercell Ag Uses for polycationic compounds
JP2004519453A (ja) * 2001-01-05 2004-07-02 インターツェル・アクチェンゲゼルシャフト ポリカチオン性化合物の用途
US6835536B2 (en) 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof
CA2458146C (en) * 2001-08-23 2012-07-24 Westgate Biological Limited Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
ATE519499T1 (de) * 2002-05-10 2011-08-15 Agennix Inc Lactoferrin bei der behandlung maligner neoplasien und anderer hyperproliferativer erkrankungen
WO2005016372A1 (en) * 2003-03-25 2005-02-24 Advitech Solutions Inc. Compositions comprising polymetal-binding proteins and plant extracts for reducing free radicals
EP1635766A4 (de) 2003-06-06 2009-09-30 Agennix Inc Lactoferrin als adjuvans in krebs-vakzinen
WO2007065128A2 (en) * 2005-11-30 2007-06-07 Auburn University Human alpha-defensins inhibit interleukin-1beta release
WO2008017661A1 (en) 2006-08-07 2008-02-14 Novozymes A/S Enzyme granules for animal feed
EP3072399B1 (de) 2006-08-07 2018-12-19 Novozymes A/S Enzymgranulat für tierfutter
JP5646507B2 (ja) * 2009-01-13 2014-12-24 ペルガムム・エイビーＰｅｒｇａｍｕｍ ＡＢ 創傷、傷跡、および手術後の癒着形成を治療するためのヒアルロン酸含有組成物
FR2967160B1 (fr) * 2010-11-09 2014-09-26 Isp Investments Inc Nouveaux peptides activateurs de la dermatopontine et composition cosmetique les comprenant
US20140315789A1 (en) * 2011-11-23 2014-10-23 Newsouth Innovations Pty Limited Antimicrobial peptides and uses thereof
CN108033995B (zh) * 2017-12-19 2020-12-29 渤海大学 两种来源于大黄鱼肌联蛋白的ace抑制肽

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0503939B1 (de) * 1991-03-13 1997-06-18 Morinaga Milk Industry Co., Ltd. Antimikrobielles Peptid und antimikrobieller Wirkstoff
DE69223844T2 (de) * 1991-04-24 1998-04-16 Morinaga Milk Industry Co Ltd Antimikrobielles Peptid und antimikrobieller Wirkstoff
DK66493D0 (da) * 1993-06-08 1993-06-08 Ferring A S Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
US5994306A (en) * 1995-11-22 1999-11-30 Intrabiotics Pharmaceuticals, Inc. Fine-tuned protegrins

Also Published As

Publication number Publication date
WO2000000214A2 (en) 2000-01-06
AU4512499A (en) 2000-01-17
ATE259654T1 (de) 2004-03-15
NZ509101A (en) 2003-07-25
AU771077B2 (en) 2004-03-11
EP1089755A2 (de) 2001-04-11
WO2000000214A3 (en) 2000-03-30
DE69914911T2 (de) 2004-12-09
JP2002519332A (ja) 2002-07-02
CA2332127A1 (en) 2000-01-06
EP1089755B1 (de) 2004-02-18

Similar Documents

Publication Publication Date Title
DE69914911D1 (de) Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
AU3698697A (en) Method for preserving infectious recombinant viruses, aqueous viral suspension and use as medicament
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
EP1283050A3 (de) Verbesserte Arzneimittelzusammensetzungen, welche ein bakterizides Permeabilität erhöhendes Protein enthalten
AU6339599A (en) Quinoline derivatives and their use as antibacterial agents
ATE427116T1 (de) Behandlung von bakteriellen infektionen
IL157041A0 (en) Monoclonal antibodies to the clfa protein and method of use in treating and preventing infections
DK0832119T3 (da) Histatinbaserede peptider mod svamp og bakterier
ES2170239T3 (es) Peptidos antifungicos de d-aminoacidos basados en histatina.
HUP0202235A2 (hu) Tartósított gyógyászati készítmények
AU3657600A (en) Biologically active compounds of (ganoderma pfeifferi) dms 13239
AU3902299A (en) Methods of treating microbial infection and therapeutic formulations therefor
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
WO2003037259A3 (en) Methods for the prevention or treatment of bacterial and fungal infections
EP0932613A4 (de) Expressionsblockierung von virulenten faktoren in s. aureus
WO2000012049A3 (en) A method for the treatment of staphylococcal disease
ATE261737T1 (de) Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
DE69631381D1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
ATE413170T1 (de) Medizinische zusammensetzung zur behandlung von infektionen mit arzneimittelresistentem staphylococcus aureus
EP0974360A3 (de) Pharmazeutische Präparate zur Bekämpfung oder Prophylaxe von Mikroorganismen infizierten Oberflächen
AU5848690A (en) Preparation for topical treatment of infections caused by virus, bacteria and fungi
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
AU2396900A (en) Treatment and prevention of hiv and other viral infections

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee